ProShare Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

ProShare Advisors’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,060	Closed	-$71K	–	2215
2022 Q1	$71K	Sell	10,060 -1,589	-14%	-$13.1K	﹤0.01%	2084
2021 Q4	$211K	Buy	+11,649	New	+$251K	﹤0.01%	1997
2021 Q3	–	Sell	-12,754	Closed	-$572K	–	2333
2021 Q2	$572K	Buy	+12,754	New	+$591K	﹤0.01%	1436

Other funds holding CELL

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ProShare Advisors's CELL Position: Q2 2022 in Review

ProShare Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 10,060 shares — an estimated $71K sold.

ProShare Advisors first reported a position in CELL in Q2 2021 and held it in 3 quarters. The position peaked at $572K in Q2 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

ProShare Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
ProShare Advisors sold 10,060 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $71K.
ProShare Advisors first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 3 quarters.
ProShare Advisors's PhenomeX Inc. Common Stock position peaked at $572K in Q2 2021.
123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.